LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
SK-BR-3 | TGX221 | 10.0 | uM | LJP5 | 0.9396 | 0.0247 | 0.9042 | 0.0358 |
SK-BR-3 | Torin1 | 10.0 | uM | LJP6 | 0.2884 | 0.0176 | -0.1894 | 0.0986 |
SK-BR-3 | Torin2 | 10.0 | uM | LJP5 | 0.2509 | 0.0306 | -0.2515 | 0.1105 |
SK-BR-3 | Tozasertib | 10.0 | uM | LJP5 | 0.3727 | 0.0085 | -0.0446 | 0.0534 |
SK-BR-3 | Trametinib | 10.0 | uM | LJP5 | 0.7782 | 0.0471 | 0.6263 | 0.0859 |
SK-BR-3 | TWS119 | 10.0 | uM | LJP5 | 0.2927 | 0.0460 | -0.1878 | 0.1470 |
SK-BR-3 | Vemurafenib | 10.0 | uM | LJP5 | 0.8827 | 0.0244 | 0.8090 | 0.0318 |
SK-BR-3 | Withaferin A | 10.0 | uM | LJP5 | 0.2478 | 0.0039 | -0.2535 | 0.0715 |
SK-BR-3 | Withaferin A | 10.0 | uM | LJP6 | 0.2653 | 0.0053 | -0.2256 | 0.0812 |
SK-BR-3 | WYE-125132 | 10.0 | uM | LJP6 | 0.3666 | 0.0212 | -0.0560 | 0.0753 |
SK-BR-3 | WZ3105 | 10.0 | uM | LJP5 | 0.2810 | 0.0464 | -0.1985 | 0.1083 |
SK-BR-3 | XMD11-50 | 10.0 | uM | LJP6 | 0.4340 | 0.0210 | 0.0525 | 0.0907 |
SK-BR-3 | Y39983 | 10.0 | uM | LJP6 | 0.3368 | 0.0160 | -0.1086 | 0.0920 |
SK-BR-3 | YM 201636 | 10.0 | uM | LJP5 | 0.4910 | 0.0247 | 0.1561 | 0.0200 |
SK-BR-3 | ZSTK474 | 10.0 | uM | LJP6 | 0.3818 | 0.0130 | -0.0307 | 0.0675 |